Release Date: February 27, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Could you elaborate on the assumptions behind your full-year 2025 guidance, particularly at the lower end of your target? Are you still expecting around EUR100 million contributions from new projects? A: The EUR100 million contribution from new projects is sensitive to macroeconomic conditions. While we expect growth in 2025, the extent will depend on macroeconomic developments. If conditions remain challenging, we might be at the lower end of the guidance. However, if the macroeconomic environment improves, we could reach the higher end of the range. Our focus remains on self-help initiatives to deliver superior performance compared to last year.
Q: Can you explain the strength in the downstream Coating Solutions business versus the weakness in upstream acrylics? Is this a supply issue? A: The weakness in upstream acrylics is not due to supply issues but rather low demand, particularly in Europe and the US. We are currently at a low point in the cycle for acrylics. However, we view this as a mid-term upside opportunity for the company, as normalized conditions could bring significant EBITDA improvements.
Q: Regarding the recurring cash flow target of EUR600 million for 2025, what should we expect in terms of nonrecurring items? A: The nonrecurring items in 2024 were significantly impacted by startup costs for the Singapore site and M&A transaction costs. Historically, nonrecurring items have been around EUR60 million. The EUR600 million target for recurring cash flow assumes normal IFRS cash flow generation, excluding lease costs.
Q: How do you view the competitive landscape in the adhesives market, especially with increased M&A activity in construction chemicals? A: The adhesives market has seen consolidation, but the competitive landscape remains stable for our product lines. We see opportunities in roofing and industrial adhesives, and we continue to participate in market consolidation. The stability of major players and consolidation of smaller ones present opportunities for growth.
Q: Can you provide more details on the impact of recent legislation on PFAS in France? A: The recent PFAS legislation in France concerns a ban on certain substances in textiles, cosmetics, and cookware. Arkema does not supply these markets, so there is no impact on our business.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。